Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells

Cancer Letters

Volumn 263, Issue 1, 2008, Pages 35-43

  Sun, Tao ^a   Sun, Bao cun ^a   Ni, Chun sheng ^a   Zhao, Xiu lan ^a   Wang, Xing hui ^a   Qie, Shuo ^a   Zhang, Dan fang ^a   Gu, Qiang ^a   Qi, Hong ^a   Zhao, Nan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Bone marrow cells; Endothelial cells; Melanoma cells; Mesenchymal stem cells; Proliferation; Tumor

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BLOOD CLOTTING FACTOR 8; ENDOGLIN; HERMES ANTIGEN; THY 1 ANTIGEN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ADIPOCYTE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOCYTE; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; MALE; MELANOMA, EXPERIMENTAL; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; PILOT PROJECTS; TUMOR CELLS, CULTURED;

EID: 41049102509     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.12.015     Document Type: Article

References (35)

1. Pittenger M., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
2. Minguell J.J., Erices A., and Conget P. Mesenchymal stem cells. Exp. Biol. Med. 226 (2001) 507-520
3. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 6 (2000) 1282-1286
4. Oswald J., Boxberger S., Jorgensen B., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22 (2004) 377-384
5. Silva G.V., Litovsky S., Assad A.R., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111 (2005) 150-156
6. Sun B.C., Zhang S.W., Ni C.S., et al. Correlation between melanoma angiogenesis and the mesenchymal stem cells and endothelial progenitor cells derived from bone marrow. Stem Cells Dev. 14 (2005) 292-298
7. Zeng L.F., Xiao Q.Z., Margariti A., et al. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J. Cell Biol. 174 (2006) 1059-1069
8. Sawa H., Murakami H., Ohshima Y., Murakami M., Yamazaki I., Tamura Y., et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. Brain Tumor Pathol. 19 (2002) 77-81
9. Liu L.T., Chang H.C., Chiang L.C., and Hung W.C. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res. 63 (2003) 3069-3072
10. Harris, and Hypoxia L.A. A key regulatory factor in tumour growth. Nat. Rev. Cancer 2 (2002) 38-47
11. Byrne A.M., Bouchier-Hayes D.J., and Harmey J.H. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J. Cell. Mol. Med. 9 (2005) 777-794
12. Di Stefano V., Soddu S., Sacchi A., and D' Orazi G. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Oncogene 24 (2005) 5431-5442
13. Zhao Y., Lu S., Wu L., Chai G., Wang H., Chen Y., et al. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol. Cell. Biol. 26 (2006) 2782-2790
14. Hombauer H., and Minguell J.J. Selective interactions between epithelial tumor cells and bone marrow mesenchymal stem cells. Br. J. Cancer 87 (2000) 1290-1296
15. Fierro F.A., Sierralta W.D., Epunan M.J., et al. Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin. Exp. Metastasis 21 (2004) 313-319
16. Huttmann A., Li C.L., and Duhrsen U. Bone marrow-derived stem cells and "plasticity". Ann. Hematol. 82 (2003) 599-604
17. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
18. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
19. Huss R., Lange C., Weissinger E.M., et al. Evidence of peripheral blood-derived, plastic-adherent CD 34 (-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells 18 (2000) 252-260
20. Majumdar M.K., Banks V., Peluso D.P., et al. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J. Cell. Physiol. 185 (2000) 98-106
21. De Ugarte D.A., Alfonso Z., Zuk P.A., et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol. Lett. 89 (2003) 267-270
22. Niyibizi C., Wang S., Mi Z., et al. The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells. Mol. Ther. 9 (2004) 955-963
23. Majumdar M.K., Thiede M.A., Mosca J.D., et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSC) and stromal cells. J. Cell. Physiol. 176 (1998) 57-66
24. Phinney D.G. Building a consensus regarding the nature and origin of mesenchymal stem cells. J. Cell. Biochem. 38 Suppl. (2002) 7-12
25. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
26. Tang Y.L., Zhao Q., Zhang Y.C., et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul. Pept. 117 (2004) 3-10
27. Shake J.G., Gruber P.J., Baumgartner W.A., et al. In-vivo mesenchymal stem cell grafting in a swine myocardial infarct model: molecular and physiologic consequences. Ann. Thorac. Surg. 73 (2002) 1919-1926
28. Itescu S., Schuster M.D., and Kocher A.A. New directions in strategies using cell therapy for heart disease. J. Mol. Med. 81 (2003) 288-296
29. Agbulut O., Menot M.-L., Li Z., Marotte F., et al. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc. Res. 58 (2003) 451-459
30. Carmeliet P., Ferreira V., Breier G., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
31. Ferrare N., Carver-Moore K., Chen H., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
32. Benavente C.A., Sierralta W.D., Conget P.A., and Minguell J.J. Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells. Growth Factors 21 (2003) 87-94
33. Majumdar M.K., Thiede M.A., Mosca J.D., et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. Cell. Physiol. 176 (1998) 57-66
34. Salvesen H.B., and Akslen L.A. Significance of tumor-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumor angiogenesis and prognosis in endometrial carcinomas. Int. J. Cancer 84 (1999) 538-543
35. McDougall S.R., Anderson A.R., Chaplain M.A., et al. Mathematical modeling of flow through vascular networks: implications for tumor-induced angiogenesis and chemotherapy strategies. Bull. Math. Biol. 64 (2002) 673-702